Intermediate Trophoblastic Tumor
1 clinical trials · Condition
◉ Watch Intermediate Trophoblastic Tumor
| Record | Firm | Date |
|---|---|---|
| Iparomlimab and Tuvonralimab (QL1706) for Intermediate Trophoblastic Tumors (NCT06941766) | Peking Union Medical College Hospital | 2025-04-15 |
Track Intermediate Trophoblastic Tumor automatically
Every clearance here is in the API, with alerts when new ones post.